Recall Register

Drug recall: Cisatracurium Besylate Injection, USP, 10mg per 5mL (2 mg per mL), Single-Dose Vial (NDC 71288-712-05), packaged as 10…

Class I FDA enforcement event 87224. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

Labeling: Label mix-up: Carton of Cisatracurium Besylate Injection, USP was observed to contain ten vials mislabeled as Phenylephrine Hydrochloride Injection, USP, but confirmed to contain Cisatracurium

Class I, in the words of FDA

a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death

Meitheal Pharmaceuticals Inc started this drug recall on 27 Jan 2021. The firm address in the FDA record is in Chicago, IL. FDA put the recall in Class I. FDA event 87224 has 1 product record. The first FDA enforcement report date is 3 Mar 2021. The record gives the status Terminated, with the termination date 16 Oct 2023. 90 of the 299 drug events that started in 2021 have more product records. The median drug event of 2021 has 1 product record. The openFDA file has 299 drug events that started in 2021 and 342 that started in 2020.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Nationwide USA

Recalling firm

Meitheal Pharmaceuticals Inc, Chicago, IL.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 87224: product records
Recall numberProductQuantityClassStatusReport date
D-0286-2021Cisatracurium Besylate Injection, USP, 10mg per 5mL (2 mg per mL), Single-Dose Vial (NDC 71288-712-05), packaged as 10 x 5 mL Single-Dose Vials per carton (NDC 71288-712-06), Rx only, Mfd. for Meitheal Pharmaceuticals, Chicago, IL 60631.34,860 vialsClass ITerminated3 Mar 2021

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class I: The highest of the three FDA recall classes.

The event in context

Drug events that started in 2021
299
Share of these events in Class I
19%
Product records in this event
1Median of the firm: 1
Events of the firm on the register
4

Other events of the firm

Official channels

Cite this page

Recall Register. FDA enforcement event 87224. https://recallregister.com/fda/i/87224/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
10 Nov 2026
Newest FDA report date on the register
4 Nov 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Nationwide USA
What quantity of product is in FDA event 87224?
The FDA record gives this quantity: 34,860 vials
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2021 have the same class?
19% of the 299 drug events that started in 2021 are in Class I.